Funding source
European Commission – Horizon Europe  

Duration
September 2024 to August 2028  

Project URL
CORDIS

Project information

Thematic keywords 

  • Endometriosis
  • Nano-technology
  • Point-of-care
  • Medical device
  • Wearable
  • Graphene field-effect transistor
  • gFET

Methodological keywords 

  • Innovation Management
  • Business modelling
  • Business planning
  • Market analysis

Project narrative

SENSOPAD represents a groundbreaking leap in addressing the challenges posed by endometriosis. The project empowers individuals through SENSOPADs, sophisticated sensors designed for self-monitoring. These devices employ cutting-edge technology to efficiently detect relevant biomarkers, providing users with valuable insights during their menstrual cycles. If initial readings indicate potential concerns, users can employ the SENSOPAD Microfluidic graphene transistor device at clinical entry points. The integration of the pad and the transistor with a mobile application and a cloud platform enhances diagnostic accuracy. In essence, SENSOPAD enables early treatment, optimising infertility care and improving patients’ quality of life by offering an autonomous and non-invasive form of screening.

WR plays a pivotal role in supporting the sustainability of SENSOPAD’s results beyond the project and maximising the project’s impact. More specifically, we (i) perform a market analysis, (ii) develop tailored business models and a comprehensive business plan, (iii) manage Intellectual Property Rights of SENSOPAD’s innovations, and (iv) lead dissemination and communication activities to drive awareness and engagement with key stakeholders.